Skip to content
← Full study record

NCT00526292 · OUTCOME

Treatment Efficacy as Defined by Complete or Partial Remission

Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant · Source last updated 2016-02-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
3 Months following treatment

Groups in this outcome

HLA Haploidentical Natural Killer Cell Infusion

HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
HLA Haploidentical Natural Killer Cell Infusion6

Reported measurements

Complete Remission
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
HLA Haploidentical Natural Killer Cell Infusion1Not reportedNot reportedNot reportedNot reported
Progression of Disease (POD)
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
HLA Haploidentical Natural Killer Cell Infusion5Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        1
    title
    Complete Remission
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        5
    title
    Progression of Disease (POD)
denoms
  1. counts
    1. group Id
      OG000
      value
      6
    units
    Participants
groups
  1. description
    HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia
    id
    OG000
    title
    HLA Haploidentical Natural Killer Cell Infusion
param Type
NUMBER
reporting Status
POSTED
time Frame
3 Months following treatment
title
Treatment Efficacy as Defined by Complete or Partial Remission
type
PRIMARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice